Kazia Therapeutics Limited. Expense From Share-based Payment Transactions With Employees
Kazia Therapeutics Limited. (KZIA) reported Expense From Share-based Payment Transactions With Employees of AUD 653.19 million for the 12-month period ending 2025-06-30, per its 20-F filed 2025-11-07.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees · last filed 2025-11-07
| Period end | Expense From Share-based Payment Transactions With Employees 12 month | Expense From Share-based Payment Transactions With Employees 12 month as first filed |
|---|---|---|
| 2025-06-30 | 653.19M AUD 20-F · filed 2025-11-07 | |
| 2024-06-30 | 532.60M AUD 20-F · filed 2025-11-07 | |
| 2023-06-30 | 1.67B AUD 20-F · filed 2025-11-07 | 1.16M AUD 20-F · filed 2023-10-26 |
| 2022-06-30 | 1.67B AUD 20-F · filed 2024-11-15 | 1.67M AUD 20-F · filed 2022-10-17 |
| 2021-06-30 | 636.38K AUD 20-F · filed 2021-10-07 | |
| 2020-06-30 | 262.11K AUD 20-F · filed 2020-10-22 | |
| 2019-06-30 | 246.39K AUD 20-F · filed 2020-10-22 | |
| 2018-06-30 | 165.22K AUD 20-F · filed 2019-10-21 | |
| 2017-06-30 | 475.19K AUD 20-F · filed 2018-10-24 |